At the Tata-Corus press briefing in London, Ratan Tata, chairman, Tata group, was hounded by photographers. "You don't want to photograph me where I'm going," he joked as he stepped into the toilet. But increasingly, Indians are stepping out of their protective environment and scouting for acquisitions abroad. More importantly, Indian businessmen, who were till recently interested in smaller markets like Africa and Asia, are flexing their muscles in mature and developed ones (see chart). The Tata group, whose Corus deal was the largest by an Indian group, inked 14 others worth nearly $1.5 billion in 2005-06. Others like Suzlon Energy, Videocon group, M&M, Ranbaxy Labs and the AV Birla group have also invested huge sums. According to consultancy firm Grant Thornton, while Indian firms spent $4.3 billion in 2005 on outbound (overseas) deals, the figure has already crossed the $15 billion mark in this calendar year. The average deal size has zoomed from $31.61 million in 2005 to over $100 million this year.
Globally, the image of Indian industrialists has changed.
Fortunately, there are many opportunities to further such ambitions. Globalisation, which proved to be the bane of Indian managements in the 1990s, is impacting the Europeans and the Americans. Thanks to the benefits of outsourcing, operations in the developed economies are more expensive and hence, unviable, compared to the units in India or China. For example, the production costs at Corus' Port Talbot plant is twice that of Tata Steel's Jamshedpur unit. To survive, Corus had to either close down its plants in Europe and shift production to low-cost bases. Or cash out, which it did. Such firms have to react with passion, and as Corus chairman Jim Leng said, "with commercial passion."
This implies that many of them will be more than willing to sell out. Today, they get attractive offers because commodity prices are still riding on an upward crest despite the correction in May this year. Explains Aditya Sanghi, country head-investment banking, Yes Bank: "European firms have been slower at adapting to India and China, both in terms of the latter's low-cost production model as well as thinking of them as markets." They have also been unwilling to change, either because of management lethargy, strict regulations, strong trade unions, or nationalistic sentiments. It's a perfect setting for Indian firms which, says Frank Hancock ofABN Amro, "are both low cost and high skill, a unique combination."
Instantly, it gives them global scale, a portfolio of recognised brands and access to huge markets. Listen to Dhoot, who feels that size matters. "Our presence is now well-acknowledged because we have acquired companies that have their footprints across the world. In colour picture tubes, we have a fifth of the global marketshare and we're talking to LG-Philips to take over their picture tube operations. We're aggressively looking at the acquisition route and will follow it as our growth strategy," explains the Videocon chairman, who aims to nearly double his group's turnover to $10 billion in the next few years.
Malvinder Singh, CMD, Ranbaxy, feels the same. "Overseas forays are meant to position yourself in new markets. There's a growing realisation that we've no option but to go global," he says. Ranbaxy has manufacturing bases in eight countries, and derives 80 per cent of its revenues from overeas units. Adds kpmg's Rohit Kapur, "The investments that Indian companies have made overseas were essential for them to become competitive on a global basis and increase visibility with customers." And G.V. Prasad, vice-chairman and CEO, Dr Reddy's Lab, which purchased German generics maker Betapharm for Euro 480 million, thinks the Indian market is not enough to "sustain our growth momentum."
Tags